Translating Pre-Clinical Research to Clinical Patient Care™
Connectyour link to the clinical analysis community |
Industry Solutions
MSACL Connect
Supporting Societies
Industry Solutions : Thermo Fisher Scientific
|
Expertise you can trust Clinical research is essential for discovering answers to real-world health questions. For this, you need repeatable results, streamlined workflows, and innovative techniques. Explore options for applications, including biomarker research, inherited disorders, cancer research, and the study of infectious diseases. Learn more about Thermo Scientific Mass Spectrometry Solutions for Clinical Research. MSACL 2024: You’ll not want to miss this year’s scientific program, which will cover the latest advances utilizing our comprehensive chromatography and mass spectrometry solutions to better shape and inform clinical laboratory decision-making. |
| Wednesday, March 20th 2024 | |
|
- |
Breakfast Workshop*: [Register]
Practical Considerations for Developing and Validating LC-MS Assays in Clinical Labs
Location: Steinbeck 1 *breakfast provided on a limited basis. |
| Thursday, March 21st 2024 | |
|
- |
Breakfast Workshop*: [Register]
Unlocking the potential for large-cohort proteomic studies with the Orbitrap Astral Mass platform
Location: Steinbeck 1 *breakfast provided on a limited basis. |
Key Resources: we invite you to explore our 2023 content below from our breakfast workshops and posters by selecting the from the items below.
2023 POSTERS >>
- POSTER -- High flow LC-MS analysis of plasma digest for protein identification >>
- POSTER -- Simultaneous Detection of Respiratory Infectious Diseases using Immunoprecipitation and Liquid Chromatography-Tandem Mass Spectrometry >>
- POSTER -- Quantitation of 77 Therapeutic and Clinical Toxicology Drugs in Dried Blood Spots using the Fully Automated Transcend DSX-1 System >>
2023 WORKSHOPS >>
- Jessica Colón-Franco, Ph.D., Cleveland Clinic Foundation >> No child lead behind: Development of a method for lead screening using dried blood spots
- Dr. Michael Lutz, Ph.D., Head of Global Business Development, Osteolabs GmbH Germany >> Advancing ICP-MS to clinical testing: A novel highly sensitive diagnostic platform for early detection and therapeutic monitoring of bone metabolic disorders
- Tony Hu, Ph.D., Professor Tulane University >> Peptidomic classification of mycobacterial proteins at sub-species resolution
- Ian Lewis, Ph.D., University of Calgary, Alberta >> LC-MS metabolomics: A new frontier in microbiology diagnostic testing
TESTIMONIALS >>
- Chris Gill, Ph.D., Professor Vancouver Island University >> Rapid MS tools to help researchers tackle opioid crisis
- Ian Lewis, Ph.D., University of Calgary >> New frontiers for pathogen detection
Join the conversation